Overview

A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.
Phase:
Phase 4
Details
Lead Sponsor:
Loma Linda University
Treatments:
Cyclosporine
Cyclosporins
Tacrolimus